Limitations, agreements, and source contact

Celgene High Risk Multiple Myeloma (MM) Revlimid Induction and Maintenance Therapy · Source last updated 2014-08-19

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

point Of Contact

email

cristina.gasparetto@duke.edu

organization

Duke University Medical Center

phone

919-668-1017

title

Cristina Gasparetto, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice